Earlier Elderly People in Urban Areas

NCT05268146 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 77

Last updated 2022-03-31

No results posted yet for this study

Summary

Social innovation in aging needs to bring new ideas and services to meet new social and welfare needs identified in recent years. In our environment, people ≥60 years old accounted for 20% -24% of the population in 2015, and it is expected to increase to ≥30% by 2050.

The objectives of this project are: To characterize the elderly (60 to 74 years) who live independently in urban areas of the province of Tarragona, to actively involve them, through a process of participatory research to generate solutions.

To achieve this goal, it is proposed to make a diagnosis of their health status (lifestyles, risk of malnutrition, and sarcopenia), and conduct focus groups including young seniors from urban areas, and stakeholders, to determine their needs, interests, and barriers for pursuing healthy lifestyles. Based on the information obtained in the diagnosis and focus groups, there will be processes for co-creating solutions based on proposed activities or changes in their immediate environment.

Conditions

  • Sarcopenia
  • Eldery People
  • Lifestyle, Healthy
  • Nutrition
  • Sleep
  • Physical Activity
  • Participatory Research

Interventions

BEHAVIORAL

Lifestyles

Co-creation process and participatory research; lifestyles

Sponsors & Collaborators

  • University Rovira i Virgili

    lead OTHER

Principal Investigators

  • Rosa Sola, Dr · University Rovira i Virgili

Eligibility

Min Age
60 Years
Max Age
74 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-01
Primary Completion
2022-03-31
Completion
2022-03-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05268146 on ClinicalTrials.gov